View Financial HealthGrapefruit USA 配当と自社株買い配当金 基準チェック /06Grapefruit USA配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Nov 16Grapefruit USA, Inc. announced delayed 10-Q filingOn 11/15/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 17Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/16/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/17/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 20Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery CreamGrapefruit USA, Inc. announced that its Notice of New Cannabis Product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Approval of Grapefruit’s NNCP was a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. As a result of the Health Canada Hourglass™ NNCP approval, Grapefruit can sell Hourglass THC-infused products throughout both California and Canada, which have a combined population in excess of 75 million people. Grapefruit believes its Hourglass™ THC/CBD delivery cream is a truly disruptive technology that will fundamentally change the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without exposure to the dangers of smoking and/or orally ingesting THC, CBD and other cannabinoids. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass technology enables users, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass-based products work without the health risks from smoking or orally ingesting THC and CBD.お知らせ • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Mar 29Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc. on March 22, 2022. Grapefruit USA, Inc. (OTCPK:GPFT) will issue a to be agreed upon number of its common shares in consideration of the Acquisition. The transaction is subject to Due Diligence Review by Diagnostic Lab Corporation, Inc., signing of a binding Letter of Intent and a Definitive Agreement. The parties will sign a binding Letter of Intent on or before April15, 2022 and will close the transaction on or before September 1, 2022.お知らせ • Mar 05Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP SubmissionGrapefruit USA, Inc. announced Notice of New Cannabis Product filed with Health Canada for its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Health Canada is the department of the federal government of Canada responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. On Feb. 18, 2022, Grapefruit received an inquiry from Health Canada about the composition of specific Hourglass ingredients. Grapefruit’s timely response to the inquiry was promptly accepted by Health Canada. Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology which has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and/or oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids.お知らせ • Feb 24Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of DirectorsGrapefruit USA, Inc. announced that its Chief Executive Officer Bradley J. Yourist has been elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’s Property Owners Association Board of Directors for a one-year term, effective immediately.お知らせ • Dec 07Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass™ TechnologyGrapefruit USA, Inc. announced the official launch of the world’s first patented time-release, hemp-based CBD topical cream with boosted bioavailability, made possible by its proprietary Hourglass™ technology. Hourglass™ is a unique method for staggered and discreet topical delivery of CBD. The brand-new technology, developed by Grapefruit, leverages a proprietary process that involves the grinding of CBD into nano sized particles, substantially smaller than the width of a human hair, which allows for significantly higher bioavailability and absorption. The nano-particle technology enables anyone who wants to enjoy the incredible holistic benefits of CBD to do so, both immediately and over a sustained period of up to 8-10 hours, in a discreet and convenient manner. The micro-sized vessels called “Z-Pods™”, lodge deep into human pores and follicles, persisting there, before slowly releasing CBD over an extended time period, forming what Grapefruit has dubbed the “Patchless-Patch™” system.お知らせ • Aug 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/17/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 15Grapefruit Usa, Inc. Expands its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet TinctureGrapefruit USA, Inc. (‘GPFT,’ ‘Grapefruit’ or the ‘Company’) announced that it is expanding its hemp-based cannabidiol (‘CBD’) product line with a new U.S. Department of Agriculture (‘USDA’) certified CBD pet tincture targeting two of the most common dog and cat ailments – anxiety and joint pain. Grapefruit’s new Pet 300 mg CBD hemp-based tincture is derived from USDA Certified Organic hemp, grown only in the United States. The pet CBD industry has experienced significant growth over the last several years, with an expected market valuation of over $1.7 billion by 2025, according to the Brightfield Group. Overall pet ownership is also increasing, due partly to the pandemic, with more than half of U.S. households having a pet dog or cat and 64% of CBD consumers are specifically buying CBD products for their pets because of the holistic benefits they provide. The global CBD pet market size was valued at USD 27.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2020 to 2027. The perceived benefits of cannabis, high awareness among pet owners, and consumers’ preference for natural pet supplements have led to an upsurge in the growth of this market.お知らせ • May 19Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/18/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 11Grapefruit USA, Inc. Launches New Affiliate Program in Conjunction with New E-Commerce StoreGrapefruit USA, Inc. announced its new Affiliate Program which will complement its new E-Commerce Store. The new Affiliate Program is designed to facilitate the ability of approved and authorized third party resellers with existing online retail platforms to market and sell Grapefruit’s THC-free hemp derived CBD Hourglass powered products.お知らせ • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Mar 16Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Now Available on Crown Genetics Mobile Retail Distribution PlatformGrapefruit USA, Inc. announced that its patented, disruptive Hourglass™ time release THC+ Cannabinoid delivery cream and full spectrum RSO cannabis oil are now available for purchase on Crown Genetics’ (“Crown”) retail delivery online platform in California under the “Wellness” section. As a result, customers who live in Los Angeles County can have Hourglass delivered to their home or office via the Crown delivery distribution system. The public will also be able to buy Hourglass™, as well as Grapefruit’s full spectrum RSO oil, at any of the over 250 California licensed retail dispensaries serviced by the Crown distribution system as soon as these products are delivered and stocked in these retail outlets. Hourglass™ and the RSO are currently available for retail purchase at the Apothecary 420 Dispensary in Sherman Oaks, California.お知らせ • Mar 09Grapefruit USA, Inc. Announces Resignation of John Hollister from the Board of DirectorsGrapefruit USA, Inc. announced that on February 26, 2021 John Hollister resigned from the Company's board of directors. Mr. Hollister's resignation was accepted by the Board.お知らせ • Mar 03Grapefruit USA, Inc. Signs Memorandum of Understanding with Canadian Partner to Form New Joint Venture Corporation to Manufacture and Distribute its Patented, Disruptive Hourglass THC/ Cannabinoid ProductsGrapefruit USA, Inc. signed a memorandum of understanding (the MOU) with a Canadian Partner which sets forth the general terms of their agreement to form a new joint venture corporation to manufacture and distribute the company’s patented, disruptive Hourglass THC/cannabinoid products, throughout the Commonwealth of Canada including on Canadian First Nation Lands. Under the terms of the MOU, products to be sold in Canada shall be manufactured in Canada in licensed facilities, and in some cases under appropriate framework on Canadian First Nations Land under license from the company by the joint venture, with the provision of technical know-how, lab staff and the patented Z-Pod by the company and provision of compliant Canadian-made THC/CBD distillates and terpenes by the Canadian Partner. Subject to certain, yet to be negotiated issues the joint venture shall be managed jointly by the company and the Canadian Partner and joint venture profits will generally be split 50%/50%, subject to certain exceptions. The Canadian Partner shall have exclusive rights with respect to sales of Hourglass products in Health Canada Permitted retail locations, and in First Nation’s Lands, from the formation of the joint venture with exclusive rights with respect to sales of Hourglass products throughout Canada for 180 days while the parties negotiate in good faith to establish unit sales minimums to support exclusivity.お知らせ • Feb 23Grapefruit USA, Inc. Secures Trademark Protection for the ‘Hourglass’ Name and LogoGrapefruit USA, Inc. announced that it has obtained California Trademark protection for Grapefruit’s patented disruptive Hourglass™ THC/Cannabinoid time-release delivery cream. The Hourglass™ name and logo are protected intellectual property rights of the Company which prevents all others operating in the Cannabis space from exploitation of such property. The Company also possesses common law, first-in-time, trademark protection to Hourglass™. The Company will obtain its Federal trademark protection when the Federal government legalizes cannabis, expected by many to be later this year.決済の安定と成長配当データの取得安定した配当: GPFTの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: GPFTの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Grapefruit USA 配当利回り対市場GPFT 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (GPFT)n/a市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Pharmaceuticals)2.2%アナリスト予想 (GPFT) (最長3年)n/a注目すべき配当: GPFTは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: GPFTは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: GPFTの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: GPFTが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/18 01:16終値2026/05/18 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Grapefruit USA, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 16Grapefruit USA, Inc. announced delayed 10-Q filingOn 11/15/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 17Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/16/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/17/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 20Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery CreamGrapefruit USA, Inc. announced that its Notice of New Cannabis Product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Approval of Grapefruit’s NNCP was a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. As a result of the Health Canada Hourglass™ NNCP approval, Grapefruit can sell Hourglass THC-infused products throughout both California and Canada, which have a combined population in excess of 75 million people. Grapefruit believes its Hourglass™ THC/CBD delivery cream is a truly disruptive technology that will fundamentally change the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without exposure to the dangers of smoking and/or orally ingesting THC, CBD and other cannabinoids. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass technology enables users, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass-based products work without the health risks from smoking or orally ingesting THC and CBD.
お知らせ • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Mar 29Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc. on March 22, 2022. Grapefruit USA, Inc. (OTCPK:GPFT) will issue a to be agreed upon number of its common shares in consideration of the Acquisition. The transaction is subject to Due Diligence Review by Diagnostic Lab Corporation, Inc., signing of a binding Letter of Intent and a Definitive Agreement. The parties will sign a binding Letter of Intent on or before April15, 2022 and will close the transaction on or before September 1, 2022.
お知らせ • Mar 05Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP SubmissionGrapefruit USA, Inc. announced Notice of New Cannabis Product filed with Health Canada for its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Health Canada is the department of the federal government of Canada responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. On Feb. 18, 2022, Grapefruit received an inquiry from Health Canada about the composition of specific Hourglass ingredients. Grapefruit’s timely response to the inquiry was promptly accepted by Health Canada. Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology which has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and/or oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids.
お知らせ • Feb 24Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of DirectorsGrapefruit USA, Inc. announced that its Chief Executive Officer Bradley J. Yourist has been elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’s Property Owners Association Board of Directors for a one-year term, effective immediately.
お知らせ • Dec 07Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass™ TechnologyGrapefruit USA, Inc. announced the official launch of the world’s first patented time-release, hemp-based CBD topical cream with boosted bioavailability, made possible by its proprietary Hourglass™ technology. Hourglass™ is a unique method for staggered and discreet topical delivery of CBD. The brand-new technology, developed by Grapefruit, leverages a proprietary process that involves the grinding of CBD into nano sized particles, substantially smaller than the width of a human hair, which allows for significantly higher bioavailability and absorption. The nano-particle technology enables anyone who wants to enjoy the incredible holistic benefits of CBD to do so, both immediately and over a sustained period of up to 8-10 hours, in a discreet and convenient manner. The micro-sized vessels called “Z-Pods™”, lodge deep into human pores and follicles, persisting there, before slowly releasing CBD over an extended time period, forming what Grapefruit has dubbed the “Patchless-Patch™” system.
お知らせ • Aug 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/17/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 15Grapefruit Usa, Inc. Expands its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet TinctureGrapefruit USA, Inc. (‘GPFT,’ ‘Grapefruit’ or the ‘Company’) announced that it is expanding its hemp-based cannabidiol (‘CBD’) product line with a new U.S. Department of Agriculture (‘USDA’) certified CBD pet tincture targeting two of the most common dog and cat ailments – anxiety and joint pain. Grapefruit’s new Pet 300 mg CBD hemp-based tincture is derived from USDA Certified Organic hemp, grown only in the United States. The pet CBD industry has experienced significant growth over the last several years, with an expected market valuation of over $1.7 billion by 2025, according to the Brightfield Group. Overall pet ownership is also increasing, due partly to the pandemic, with more than half of U.S. households having a pet dog or cat and 64% of CBD consumers are specifically buying CBD products for their pets because of the holistic benefits they provide. The global CBD pet market size was valued at USD 27.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2020 to 2027. The perceived benefits of cannabis, high awareness among pet owners, and consumers’ preference for natural pet supplements have led to an upsurge in the growth of this market.
お知らせ • May 19Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/18/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 11Grapefruit USA, Inc. Launches New Affiliate Program in Conjunction with New E-Commerce StoreGrapefruit USA, Inc. announced its new Affiliate Program which will complement its new E-Commerce Store. The new Affiliate Program is designed to facilitate the ability of approved and authorized third party resellers with existing online retail platforms to market and sell Grapefruit’s THC-free hemp derived CBD Hourglass powered products.
お知らせ • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Mar 16Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Now Available on Crown Genetics Mobile Retail Distribution PlatformGrapefruit USA, Inc. announced that its patented, disruptive Hourglass™ time release THC+ Cannabinoid delivery cream and full spectrum RSO cannabis oil are now available for purchase on Crown Genetics’ (“Crown”) retail delivery online platform in California under the “Wellness” section. As a result, customers who live in Los Angeles County can have Hourglass delivered to their home or office via the Crown delivery distribution system. The public will also be able to buy Hourglass™, as well as Grapefruit’s full spectrum RSO oil, at any of the over 250 California licensed retail dispensaries serviced by the Crown distribution system as soon as these products are delivered and stocked in these retail outlets. Hourglass™ and the RSO are currently available for retail purchase at the Apothecary 420 Dispensary in Sherman Oaks, California.
お知らせ • Mar 09Grapefruit USA, Inc. Announces Resignation of John Hollister from the Board of DirectorsGrapefruit USA, Inc. announced that on February 26, 2021 John Hollister resigned from the Company's board of directors. Mr. Hollister's resignation was accepted by the Board.
お知らせ • Mar 03Grapefruit USA, Inc. Signs Memorandum of Understanding with Canadian Partner to Form New Joint Venture Corporation to Manufacture and Distribute its Patented, Disruptive Hourglass THC/ Cannabinoid ProductsGrapefruit USA, Inc. signed a memorandum of understanding (the MOU) with a Canadian Partner which sets forth the general terms of their agreement to form a new joint venture corporation to manufacture and distribute the company’s patented, disruptive Hourglass THC/cannabinoid products, throughout the Commonwealth of Canada including on Canadian First Nation Lands. Under the terms of the MOU, products to be sold in Canada shall be manufactured in Canada in licensed facilities, and in some cases under appropriate framework on Canadian First Nations Land under license from the company by the joint venture, with the provision of technical know-how, lab staff and the patented Z-Pod by the company and provision of compliant Canadian-made THC/CBD distillates and terpenes by the Canadian Partner. Subject to certain, yet to be negotiated issues the joint venture shall be managed jointly by the company and the Canadian Partner and joint venture profits will generally be split 50%/50%, subject to certain exceptions. The Canadian Partner shall have exclusive rights with respect to sales of Hourglass products in Health Canada Permitted retail locations, and in First Nation’s Lands, from the formation of the joint venture with exclusive rights with respect to sales of Hourglass products throughout Canada for 180 days while the parties negotiate in good faith to establish unit sales minimums to support exclusivity.
お知らせ • Feb 23Grapefruit USA, Inc. Secures Trademark Protection for the ‘Hourglass’ Name and LogoGrapefruit USA, Inc. announced that it has obtained California Trademark protection for Grapefruit’s patented disruptive Hourglass™ THC/Cannabinoid time-release delivery cream. The Hourglass™ name and logo are protected intellectual property rights of the Company which prevents all others operating in the Cannabis space from exploitation of such property. The Company also possesses common law, first-in-time, trademark protection to Hourglass™. The Company will obtain its Federal trademark protection when the Federal government legalizes cannabis, expected by many to be later this year.